Dr. Malini Surapaneni, MD

Dr. Surapaneni practices at IU Health Methodist Hospital in Indianapolis, Indiana, part of Indiana University Health.

Dr. Surapaneni's NPI, 1811342843, was assigned on April 27, 2016. Dr. Surapaneni holds Indiana license 01090940A.

Dr. Surapaneni's primary practice is IU Health Methodist Hospital, at 1701 N Senate Blvd, Indianapolis, IN 46202 in Marion County. The practice phone is (317) 962-2000.

Dr. Surapaneni's primary practice is IU Health Methodist Hospital in Indianapolis, Indiana, part of Indiana University Health. Dr. Surapaneni is also affiliated with Sidney & Lois Eskenazi Hospital. The medical group on file is IU Health Medical Group. Dmand AI also links Dr. Surapaneni to 3 more hospitals, 2 group practices and clinics, 1 behavioral health center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Surapaneni practices, 8 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Surapaneni's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Surapaneni is licensed in Indiana.

CMS data shows 245 Medicare services from Dr. Surapaneni across 5 procedure codes in 2024, for 128 Medicare patients. Medicare paid $20,185 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 128 Medicare patients who saw Dr. Surapaneni in 2024. The largest group is 65 to 74, with 58 patients. 75% of them have high blood pressure, and 66% have high cholesterol. 27% are also on Medicaid. Their average risk score is 2.46, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Surapaneni's median patient age at 60, with 62% women.

In 2024, Dr. Surapaneni wrote 234 Medicare Part D claims for 47 patients. 60% of them were for generic drugs. CMS names the drug for 170 of them, across 10 drugs with 11 or more claims each, at $907,502 in total drug cost. In 2022, CMS named 45 claims across 3 drugs.

Dr. Surapaneni accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Surapaneni as offering telehealth.

Dmand AI links 8 papers to Dr. Surapaneni, published from 2016 to 2025. 2019 was the busiest year, with 3. The most frequent topics are Hematopoietic Stem Cell Transplantation, Graft vs Host Disease and Transplantation Conditioning. Dr. Surapaneni has published most often in Leuk Lymphoma. Dr. Surapaneni's most frequent co-authors are Lois J. Ayash, MD, Abhinav Deol, MD and Joseph P. Uberti, MD, PhD.

CMS Open Payments shows 2 general payments to Dr. Surapaneni from 2 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $140.